Answers are grounded in this paper and cite their sources.
Multisource exchangeability models (MEMs), a BayeTsian approach for dynamically integrating information from multiple clinical trials, are a promising approach for gaining efficiency in randomized controlled trials. When the supplementary trials are considerably larger than the primary trial, care must be taken when integrating supplementary data to avoid overwhelming the primary trial. In this paper, we propose “capping priors,” which controls the extent of dynamic borrowing by placing an a priori cap on the effective supplemental sample size. We demonstrate the behavior of this technique via simulation, and apply our method to four randomized trials of very low nicotine content cigarettes.
No takes yet. Share an insight, caveat, or question.
Ling et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: